newsfilter
← Latest News
PR Newswire·

Kindred Biosciences Announces Half-Life Extension Technology for Canine Antibodies

Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today...